Improving Patient Care

Ipsen Biopharmaceuticals, Inc. is a subsidiary of the Ipsen Group, a global pharmaceutical company based in France. A specialty biotech company, Ipsen US strives to improve health, as some diseases pose unique challenges to patients. At Ipsen Biopharmaceuticals, Inc., we embrace our responsibility to these patients and recognize that important advances are more likely when we share knowledge and resources with others.

Medical Information Requests

This page is provided and intended to direct US Health Care Professionals to an Ipsen Medical Information Professional for response to unsolicited requests for medical information. To obtain medical Information related to Dysport, Increlex and/or Somatuline Depot, please contact us by one of the following methods:

By phone:   (855) 463-5127
Email:           medinfo.usa@ipsen.com
Fax:              (866) 681-1063

Ipsen Biopharmaceuticals, Inc. Educational Grants: Scientific and Medical Community

Ipsen Biopharmaceuticals, Inc. values and continues to pursue partnerships with the scientific and clinical communities to develop therapies that can improve the lives of patients. We fund requests for healthcare provider or patient education from the medical and scientific community, academic institutions, state or national medical associations or societies, disease foundations and associations, patient associations, or other educational providers.

Ipsen Biopharmaceuticals, Inc.'s areas of therapeutic interest fall into three categories: endocrinology, neurology, and oncology. In particular, we are interested in funding education relating to acromegaly and neuroendocrine tumors and neuromuscular and movement disorders. Request a Grant

Additionally, Ipsen Biopharmaceuticals, Inc. considers providing funding for patient care organizations and groups that provide education and raise awareness within the endocrine and neurology therapeutic areas through educational seminars, materials, or other mechanisms. Request a Grant